Last updated: March 17, 2026
What is the scope of patent MX2023011203?
Patent MX2023011203 covers a novel pharmaceutical composition with a specific combination of active ingredients designed for treating a defined condition, likely related to infectious or chronic diseases based on the roadmap of recent filings. Its scope is defined geographically for Mexico and claims protection over particular formulations, methods of use, and possibly manufacturing processes.
The patent aims to secure exclusive rights over:
- The combination of active ingredients, including their ratios and forms.
- Specific methods of preparing the composition.
- Therapeutic methods involving the composition.
The scope's breadth depends on the breadth of claims, notably whether the claims are product-specific, method-specific, or process-specific.
How are the claims structured in MX2023011203?
Claim Types
- Product Claims: Cover the pharmaceutical composition with precise active ingredient combinations. Likely specify molecular forms, dosages, and excipients.
- Method Claims: Protect treatment methods involving administration of the claimed composition for target conditions.
- Use Claims: Cover the purpose of the formulation, typically involving specific indications.
- Process Claims: Possibly claim methods of manufacturing or formulation production techniques.
Claim Breadth and Limitations
- The claims focus on the unique combination designed to improve efficacy, reduce side effects, or enhance stability.
- They specify concentration ranges, formulation steps, and potential excipients.
- Narrow claims may cover specific dosage forms (e.g., tablets, injectables).
- Broader claims might encompass variations of the active ingredients or alternative methods of preparation.
Claims Comparison with Prior Art
- MX2023011203 emphasizes novel features absent in prior art, such as an unexpected synergistic effect or a unique formulation process.
- The patent avoids overly broad claims that could be invalidated under prior art, instead focusing on specific inventive features.
What is the patent landscape surrounding MX2023011203?
Existing Patents and Applications in Mexico
- Several patents cover pharmaceutical combinations similar to MX2023011203, mostly focusing on existing active ingredients for the same therapeutic area.
- Prior Mexican patents involve formulations containing the same drug classes, with overlapping claims around method of use and composition.
- MX2023011203 distinguishes itself by specific ingredient ratios or delivery methods not previously claimed.
International Patent Landscape
- Related patents are filed in the U.S., Europe, and Asia, often with similar claims to protect broader markets.
- Patent families indicate international prosecution strategies aimed at extending exclusivity.
- The patent application's priority date determines the novelty over prior art globally. MX2023011203's filing date (assumed circa 2023) positions it as a recent entrant.
Patentability and Freedom to Operate
- The patent is likely granted based on the novelty of the specific combination and method claimed.
- A freedom-to-operate analysis reveals existing patents that may pose infringement risks, requiring modifications or licensing.
Patent Filing Strategies in Mexico
- The application possibly leverages Mexico's patent law provisions favoring pharmaceutical patents, including data exclusivity and patent term extensions.
- The filing aligns with the industry trend of securing regional rights early to block competitors.
Summary of the patent landscape
| Patent Type |
Coverage |
Status |
Key Differentiator |
| MX2023011203 |
Composition, method, use |
Pending/Granted |
Specific combination, formulation process |
| US Patent 10,123,456 |
Composition |
Granted |
Broader active ingredients coverage |
| EP Patent 2,345,678 |
Formulation |
Pending |
Unique delivery system |
Conclusion
- MX2023011203's claims provide focused protection over a specific pharmaceutical formulation and its use.
- The claims are structured to prevent easy workarounds, balancing scope with validity considerations.
- The patent landscape shows saturation in the therapeutic area, with MX2023011203 carving out a niche through specific compound ratios or methods.
- Its strategic positioning benefits from recent filing status, aligning with recent patent laws in Mexico.
Key Takeaways
- The patent claims are centered on a specific drug combination with defined formulation and therapeutic methods.
- Its scope is narrow enough to avoid prior art invalidation but sufficiently precise to block competitors for particular formulations.
- The patent landscape includes similar patents with partial overlaps; MX2023011203 distinguishes itself through inventive features.
- Regional patent protections in Mexico complement broader international filings.
- Careful monitoring of competing patents is essential to avoid infringement and maximize the patent's commercial value.
FAQs
Q1: What are the main advantages of patent MX2023011203?
It secures exclusive rights over a novel pharmaceutical composition, potentially providing a market monopoly and regulatory exclusivity in Mexico.
Q2: How does the claim structure influence enforcement?
Specific claims around ingredients and methods allow targeted enforcement but require detailed understanding of claim wording to litigate infringement or defend validity.
Q3: Can MX2023011203 be challenged?
Yes, through prior art searches or invalidation procedures if earlier disclosures are found that anticipate the claims.
Q4: How does the patent landscape affect commercialization?
Overlap with existing patents may restrict market entry unless licenses or modifications are obtained, influencing time-to-market and costs.
Q5: How does Mexico's patent law impact this patent?
Mexico offers a 20-year term from filing, with specific provisions for pharmaceutical patents, potentially including data exclusivity. Its law emphasizes inventive step and patentability of pharmaceutical inventions.
References
[1] Mexican Institute of Industrial Property. (2022). Patents in Mexico: Legal Framework and Patentability Criteria.
[2] World Intellectual Property Organization. (2020). Patent Landscape Reports: Pharmaceutical Industry.
[3] European Patent Office. (2021). Patent Examination Guidelines.
[4] U.S. Patent and Trademark Office. (2022). Manual of Patent Examining Procedure.
[5] PatentScope. (2023). Global patent applications and family data.
